NVS Novartis AG

143.11USD-0.12%Mkt Cap: 272.01B $P/E: 21.62

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to tre…

Key Statistics

Company
Market Cap272.01B USD
Enterprise Value309.40B USD
Revenue (TTM)56.69B USD
Gross Profit42.98B USD
Net Income (TTM)13.98B USD
Revenue/Share29.64 USD
Last Price143.11 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees75.3K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)21.62
P/E (Forward)14.31
PEG3.30
EV/EBITDA13.39
EV/Revenue5.46
P/S4.72
P/B6.44
EPS (TTM)6.62
EPS (Forward)9.84
52W Range
121.5744% of range170.46
52W High170.46 USD
52W Low121.57 USD
Profitability
Gross Margin75.83%
Oper. Margin34.62%
EBITDA Margin40.74%
Profit Margin24.67%
ROE30.31%
ROA12.60%
Growth
Revenue Growth0.80%
Earnings Growth-17.00%
Cash Flow & Leverage
Operating CF19.14B USD
CapEx (TTM)3.90B USD
FCF Margin20.99%
FCF Yield4.37%
Net Debt41.40B USD
Net Debt/EBITDA1.79
Balance Sheet
Debt/Equity0.77
Current Ratio0.86
Quick Ratio0.55
Book Value/Sh21.86 USD
Cash/Share4.01 USD
Dividends
Fwd Div Rate4.74 USD
Trail. Div Rate4.67 USD
Div. Yield3.36%
5Y Avg Yield3.48%
Payout Ratio71.60%
Ex-Div DateMar 11, 2026
Pay DateMar 16, 2026
Splits
Last Split1116:1000
Split DateApr 9, 2019
Analyst Consensus
Rating2.6 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)155.01 USD
Upside (mean)+8.3%
Target Range130.00 USD – 185.00 USD
130.00+8.3% to mean185.00
# Analysts11
Ownership
Shares Out.1.90B
Float1.86B
Insiders0.01%
Institutions7.27%
Short Interest
Short Ratio2.2d
Short % Float0.27%
Short % Out.0.27%
Shares Short5.20M
Short (prev mo.)4.99M
Technical
SMA 50150.24 (-4.7%)
SMA 200150.76 (-5.1%)
Beta0.47
S&P 52W Chg15.78%
Avg Vol (30d)2.34M
Avg Vol (10d)1.94M
Technical Indicators
RSI (14)46.3
MACD-1.8142
MACD Signal-2.2940
MACD Hist.+0.4799
BB Upper146.70 USD
BB Middle141.70 USD
BB Lower136.71 USD
BB Width7.05%
ATR (14)2.756 USD
Vol Ratio (20d)0.78x